The Renal Biomarkers Market is estimated to be valued at US$ 1,476.2 million in 2021 and is expected to exhibit a CAGR of 8.2% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.Market Overview:The Renal Biomarkers Market focuses on the development and commercialization of biomarkers that can be used for the early detection and diagnosis...
Renal biomarkers are biochemical indicators measured and evaluated for diagnostic and prognostic purposes related to kidney diseases. They are used for detection of kidney injury, disease prognosis, evaluation of dialysis efficiency and monitoring of kidney transplant rejection. Common renal biomarkers include serum creatinine, cystatin C, kidney injury molecule 1, neutrophil...